Zim Laboratories Ltd
NSE:ZIMLAB

Watchlist Manager
Zim Laboratories Ltd Logo
Zim Laboratories Ltd
NSE:ZIMLAB
Watchlist
Price: 75.25 INR 7.25% Market Closed
Market Cap: ₹3.7B

Operating Margin

5.4%
Current
Declining
by 1.4%
vs 3-y average of 6.8%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.4%
=
Operating Income
₹199.1m
/
Revenue
₹3.7B

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
5.4%
=
Operating Income
₹199.1m
/
Revenue
₹3.7B

Peer Comparison

Country Company Market Cap Operating
Margin
IN
Zim Laboratories Ltd
NSE:ZIMLAB
3.7B INR
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
CH
Roche Holding AG
SIX:ROG
271.7B CHF
Loading...
UK
AstraZeneca PLC
LSE:AZN
212.2B GBP
Loading...
CH
Novartis AG
SIX:NOVN
220.1B CHF
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
FR
Sanofi SA
PAR:SAN
95.6B EUR
Loading...

Market Distribution

In line with most companies in India
Percentile
41st
Based on 5 437 companies
41st percentile
5.4%
Low
-153 833.3% — 2.7%
Typical Range
2.7% — 13.2%
High
13.2% — 9 977%
Distribution Statistics
India
Min -153 833.3%
30th Percentile 2.7%
Median 7.3%
70th Percentile 13.2%
Max 9 977%

Zim Laboratories Ltd
Glance View

Market Cap
3.7B INR
Industry
Pharmaceuticals

Zim Laboratories Ltd. is a pharmaceutical company. The company is headquartered in Nagpur, Maharashtra. The company went IPO on 2018-06-08. The firm develops, manufactures and supplies oral, solid differentiated generic pharmaceutical formulations and pre-formulation intermediaries (PFI) in various therapeutic segments. Its delivery solutions cover product conceptualization product development, filing for registration, manufacture, and supply of various pharmaceutical formulations. The company is developing products in various therapeutic segments like, central nervous system, anti-biotic and anti-infective, gastrointestinal, cardiovascular, analgesic/pain management, urology and vitamins, minerals, and dietary supplements. Its technological capabilities include drug release modification, solubility and stability enhancement, taste masking and dosage form transformation. Its product offerings include finished formulations and pre-formulations intermediates, which include granules, pellets, taste-masked powders, dry suspensions, tablets, capsules, and oral thin films.

ZIMLAB Intrinsic Value
HIDDEN
Show
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
5.4%
=
Operating Income
₹199.1m
/
Revenue
₹3.7B
What is Zim Laboratories Ltd's current Operating Margin?

The current Operating Margin for Zim Laboratories Ltd is 5.4%, which is below its 3-year median of 6.8%.

How has Operating Margin changed over time?

Over the last 2 years, Zim Laboratories Ltd’s Operating Margin has decreased from 7.6% to 5.4%. During this period, it reached a low of 5.4% on Jul 30, 2025 and a high of 7.6% on May 30, 2023.

Back to Top